Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
4.2%
1w
5.3%
1m
14.1%
3m
2.9%
6m
20.9%
1y
15.8%
all
10.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,283 4.2%
1,238
1,614
Company Overview
Sales
1,108 Cr
Growth: -8.7%
Profit after Tax
275 Cr
Growth: 5.5%
Mid Cap
13,421 Cr
P/E: 49.2x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 1,108
Growth -8.7%
EBITDA 35.0%
P/S 12.1x
Dividend 0.6%
P/E 49.2x
Book Value ₹ 198
PEG Ratio -5.7x
ROE 13.8%
P/B 6.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (24 Indices) view more
Followers (1)
varsha96